University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio (UTHSCSA) is an institute of health science education and research, located in the South Texas Medical Center. UTHSCSA is the largest health sciences university in South Texas. Located in the South Texas Medical Center, it serves San Antonio and all of the 50,000 square miles (130,000 km) area of central and south Texas. It extends to campuses in the metropolitan border communities of Laredo and the Rio Grande Valley. With 24,000 graduates, more than 3,000 students a year train in an environment that involves more than 100 affiliated hospitals, clinics and health care facilities in South Texas. The university offers over 65 degrees, the majority of them being graduate and professional degrees, in the biomedical and health sciences fields. UTHSCSA is home to the Cancer Therapy & Research Center (CTRC) - a major National Cancer Institute supported Center. The CTRC's Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world.
Prostate cancer treatment study changing the way doctors practice
A study published today in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer.
Cancer
Apr 04, 2013 |
not rated yet |
2
By guessing, clinicians may miss 3/4 of alcohol problems
By relying on hunches rather than posing a few screening questions, primary care clinicians may be missing three-fourths of the alcohol problems in their patients, a newly released analysis shows.
Addiction
Feb 13, 2013 |
not rated yet |
0
Link found between insulin sensitivity, cells' powerhouses
If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat ...
Medical research
Jan 29, 2013 |
4.5 / 5 (2) |
0
|
Study: Antiretroviral therapy for HIV-1 in first four months is crucial
Patients who are started on antiretroviral therapy for HIV-1 infection within four months of estimated infection date—and who have higher counts of CD4+ T-cells at the initiation of therapy—demonstrate a stronger recovery ...
HIV & AIDS
Jan 16, 2013 |
not rated yet |
0
|
Brake on nerve cell activity after seizures discovered: Gene expression initiates protective electrical response
Given that epilepsy impacts more than 2 million Americans, there is a pressing need for new therapies to prevent this disabling neurological disorder. New findings from the neuroscience laboratory of Mark ...
Neuroscience
Dec 19, 2012 |
5 / 5 (3) |
0
|
New hope for taming triple-negative breast cancer
Disease-free survival is short-lived for women with triple-negative breast cancer—a form of the disease that doesn't respond to hormone drugs and becomes resistant to chemotherapy. Thankfully, a promising ...
Cancer
Oct 02, 2012 |
5 / 5 (2) |
0
Childhood virus RSV shows promise against adult cancer
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
|
Researchers see low-calorie diet's effects in fly brain, mouthpart
A novel technique for measuring tiny, rapid-fire secretions in the brains and mouthparts of fruit flies (drosophila) is providing insights into the beneficial effects of eating less — information that ...
Medical research
Jul 16, 2012 |
5 / 5 (1) |
2
|
Air in expectant moms' homes contains pesticides, border study finds
Air samples from homes of Hispanic mothers-to-be along the Texas-Mexico border contained multiple pesticides in a majority of the houses, according to a study conducted by the School of Medicine at The University of Texas ...
Health
Jul 11, 2012 |
not rated yet |
0
Doctors overlook chemical illnesses, study finds
Chemical intolerance contributes to the illnesses of 1 in 5 patients but the condition seldom figures in their diagnosis, according to clinical research directed by a UT Medicine San Antonio physician.
Health
Jul 10, 2012 |
5 / 5 (2) |
0
Hormone curbs depressive-like symptoms in stressed mice
A hormone with anti-diabetic properties also reduces depression-like symptoms in mice, researchers from the School of Medicine at the UT Health Science Center San Antonio reported today.
Medical research
Jul 09, 2012 |
not rated yet |
0
|
Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.
Cancer
Jul 09, 2012 |
not rated yet |
0
|
Easter Island drug raises cognition throughout life span
Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with ...
Alzheimer's disease & dementia
Jun 29, 2012 |
4 / 5 (4) |
0
|
Revised ARDS definition sets out levels of severity
An international task force this week unveiled a revised definition of acute respiratory distress syndrome (ARDS), a disease first recognized during the Vietnam War in casualties with limb injuries who had trouble breathing.
Diseases, Conditions, Syndromes
May 22, 2012 |
not rated yet |
0
Behavioral support from peers, staff lowers patients' blood pressure
Behavioral support from peers and primary care office staff can help patients improve their blood pressure control by as much as starting a new drug, a new study found. Barbara J. Turner, M.D., M.S.Ed., M.A., M.A.C.P., of ...
Health
May 21, 2012 |
not rated yet |
0
